Cyteir Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $48,170,000.
Profit Margin
| 2019 | 8K | -15.04M | -188050% |
|---|---|---|---|
| 2020 | 0 | -20.82M | |
| 2021 | 0 | -41.64M | |
| 2022 | 0 | -43.95M |
CYT Income Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 8K |
Cost of revenue | 1.37M | 479K | 351K | 12.68K |
Gross profit | -1.37M | -479K | -351K | -4.68K |
Operating exp. | ||||
Research and development | 34.62M | 30.95M | 16.76M | 12.76M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 48.17M | 42.25M | 20.94M | 16.10M |
Operating income | -48.17M | -42.25M | -20.94M | -16.10M |
Other income (expenses), net | 2.10M | 133K | 120K | 1.06M |
Income before tax | -46.06M | -42.12M | -20.82M | -15.04M |
Income tax expense | -2.10M | -479K | 0 | 0 |
Net income | -43.95M | -41.64M | -20.82M | -15.04M |
Earnings per share | ||||
Basic EPS | -1.25 | -2.14 | -0.87 | -0.77 |
Diluted EPS | -1.25 | -2.14 | -0.87 | -0.77 |
| Data source | Data source |